Adial Pharmaceuticals financials
$4.15+2.72%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | -$1.2M |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating income | -$7.8M | -$8.3M | -$6.9M | -$10.9M | -$19.3M | -$10.9M | -$8.2M | -$8.2M |
| Net income | -$8.0M | -$13.2M | -$5.1M | -$12.7M | -$19.4M | -$10.9M | -$8.6M | -$11.6M |
| Net margin | — | — | — | — | — | — | — | — |
| Diluted EPS | $-11.93 | $-68.01 | $-90.00 | $-317.75 | $-650.00 | $-543.75 | $-543.75 | $-1525.00 |
| EBITDA | -$7.8M | -$8.3M | -$6.9M | -$10.9M | -$17.7M | -$10.9M | -$8.2M | -$8.2M |
| Operating cash flow | -$6.5M | -$6.9M | -$6.8M | -$11.2M | -$11.9M | -$7.6M | -$6.3M | -$2.5M |
| Free cash flow | -$6.5M | -$6.9M | -$6.8M | -$11.2M | -$12.0M | -$7.6M | — | — |
| Diluted shares | 0.7M | 0.2M | 0.1M | 0.0M | 0.0M | 0.0M | 0.0M | 0.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.9M | $3.8M | $2.8M | $4.0M | $6.1M | $4.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — | — |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $1.1M | $0.00 |
| Total assets | $6.7M | $5.0M | $4.7M | $5.7M | $7.5M | $5.5M |
| Total liabilities | $1.4M | $975.9K | $653.1K | $2.5M | $4.0M | $1.5M |
| Shareholders' equity | $5.3M | $4.1M | $4.1M | $3.3M | $3.5M | $4.0M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology